CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 161 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2016. The put-call ratio across all filers is 1.47 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $487,000 | -55.1% | 4,311 | -60.2% | 0.00% | -100.0% |
| Q1 2017 | $1,085,000 | -84.0% | 10,835 | -82.8% | 0.00% | -85.7% |
| Q4 2016 | $6,775,000 | +41.8% | 63,020 | +64.2% | 0.01% | +40.0% |
| Q3 2016 | $4,777,000 | +26.1% | 38,378 | +7.7% | 0.01% | +25.0% |
| Q2 2016 | $3,788,000 | -20.2% | 35,621 | -14.1% | 0.00% | -33.3% |
| Q1 2016 | $4,748,000 | -3.5% | 41,473 | +20.1% | 0.01% | 0.0% |
| Q4 2015 | $4,918,000 | +595.6% | 34,522 | +338.4% | 0.01% | +500.0% |
| Q3 2015 | $707,000 | +6.3% | 7,875 | +36.4% | 0.00% | 0.0% |
| Q2 2015 | $665,000 | -28.4% | 5,774 | -40.6% | 0.00% | 0.0% |
| Q1 2015 | $929,000 | +97.2% | 9,726 | +38.8% | 0.00% | – |
| Q4 2014 | $471,000 | +3.3% | 7,007 | -17.0% | 0.00% | – |
| Q3 2014 | $456,000 | – | 8,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
| RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
| Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
| Kylin Management | 188,226 | $21,676,000 | 2.36% |
| Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
| Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
| OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
| Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
| Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |